News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Seats Are Limited at ExL Pharma's Leading PR and Communications Event for Pharma, July 27-28, 2009, New York

7/9/2009 9:27:49 AM

NEW YORK, NY--(Marketwire - July 09, 2009) -

ExL Pharma's Public Relations and Communications Summit for Pharmaceutical, Biotech and Medical Technology Communicators has been the leading event of its kind for five years. This year, the Summit is being hosted at the Pfizer World Headquarters in New York, NY. The Summit features over forty-five speakers and offers tremendous learning and networking opportunities. Industry executives will join together in sharing best practices and concrete strategies for successful public relations and communications activities in a time of ever-present change.

Highlights of Discussed Topics:

-- Prepare for, Anticipate and Manage Change within External and Internal Communications -- Understand the Regulatory Framework of Social Media Communications -- Gain Strategies for Ensuring Meaningful, Analytical Media Coverage of Health Care Issues -- Restore Public Trust through Thoughtful Communications: Is it Possible? -- Manage Internal Fears and Concerns during a Time of Layoffs, Budget Cuts, Changes to Organizational Structure and Overall Uncertainty

Participating Companies:

Acorda Therapeutics, Amgen, AstraZeneca, Bayer, Baxter, BD, Bernard Associates, Biogen Idec, Bloomberg, BNET, Boehringer Ingelheim, Cephalon, Daiichi Sankyo, Davies, Delta Air Lines, Eagle Productivity Solutions, Eli Lilly, EmPower Research, Endo, EurekaAlert!, Eisai, FDA, Fleishman-Hillard, Galderma, Genzyme, Gilead Sciences, GlaxoSmithKline, Green Room Public Relations, Healthcare Institute of New Jersey, Langham Hotels International, McDermott Will & Emery, MedImmune, Merck, MS&L, Pfizer, Reuters, Roche, Target: Health, Takeda, Teva, Thomson Reuters, Sanofi-Aventis, Sanofi Pasteur, Schering-Plough, Solvay, Vertex, Watson Wyatt Worldwide, and Wyeth

This event will sell out, but it is not too late to register. For full event details and to reserve your spot, please visit Save 15% off registration by entering discount code: P228MW2 or call 866-207-6528 and mention this press release.

Snapshot of Speakers:

-- Melissa Brotz, Divisional Vice President, External Communications, Corporate Public Affairs, ABBOTT -- David Krawitz, Executive Director, Global Reputation Management & Product Communications, AMGEN -- Steve Lampert, Executive Director, Corporate Affairs, ASTRAZENECA -- Adrienne Jackson, Director of Communications, BAYER -- Tim Hunt, Vice President, Public Affairs, BIOGEN IDEC -- Richard Salem, Executive Director, Public Affairs, DAIICHI SANKYO -- Patti Futrell, General Manager, Leadership & Employee Communications, DELTA AIR LINES -- Bob Laverty, Vice President, corporate communications, EISAI -- Julie Zawisza, Director, Office of Communications, FDA CENTER FOR DRUG EVALUATION AND RESEARCH -- Stef Mendell, Director of Communications, Global Manufacturing & Supply, GLAXOSMITHKLINE -- Sally Susman, Senior Vice President and Chief Communications Officer, PFIZER -- Cathy Cantone, Director, Public/Advocacy Relations, SCHERING-PLOUGH -- Denise Bradley, Senior Director, North America corporate communications, TEVA PHARMACEUTICALS -- Wendy Kouba, Vice President, Communications, WYETH ~and many more~

If you have any questions, please contact Lindsay Slater, Conference Director, at

About ExL Events -

ExL Pharma, a division of ExL Events, Inc., is an emerging international leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community.

Lindsay Slater
ExL Pharma
Phone 212-400-6233
Email Contact

Digg this    Bookmark with    Add to Newsvine


Read at

comments powered by Disqus